Stranák Z, Velebil P, Mechurová A
Ustav pro péci o matku a díte, Praha.
Sb Lek. 2003;104(4):345-52.
Recently used antenatal steroids for induction of fetus lung maturity remain as standard procedure in the treatment of premature labour. However, the effect of antenatal steroids to the fetus may not be only the positive one.
Investigate the role of antenatal steroids on total mortality and severe morbidity in extremely low birth weight newborns under 1000 grams.
Comparative case-control study.
Institute for the Care of Mother and Child, Prague, Czech Republic.
Antenatal steroids were used in 55 cases (group ANS+) and no steroids were used in 65 control newborns (group ANS-). Both study groups were comparable in birth weight, gestational age, gender, mode of delivery and presence of intrauterine growth retardation. Statistical significant difference was in time of premature rupture of membrane (ANS+ 108+/-228 hrs versus ANS- 27+/-56 hrs, p<0.007). The Epi Info 6 (CDC, U.S.) software package and ANOVA was used for statistical analysis.
We have found statistical significant differences in total mortality (ANS+ 22%, ANS- 45%, p<0.008), in severity of respiratory distress syndrome (ANS+ median 2, ANS- median 3, p<0.0008), in total cumulative dose of surfactant (ANS+ 73 mg, ANS- 111 mg, p<0.0003), in the incidence of periventricular-intraventricular haemorrhage (ANS+ median 1, ANS- median 2, p<0.005) and posthaemorrhagic hydrocephalus (ANS+ 6%, ANS- 23%, p<0.008). Statistical significant differences were also in CRIB value (ANS+ median 7, ANS- median 11, p<0.007) and NEOMOD value (ANS+ median 5, ANS- median 7, p<0.002). In the other parameters (pneumothorax, sepsis, patent ductus arteriosus, necrotizing enterocolitis, periventricular leukomalacia) no statistical differences were found.
Our study confirmed positive effect of antenatal steroids on mortality, severe respiratory morbidity and incidence of intraventricular haemorrhage. No negative effect of antenatal steroids to higher frequency of infection complications and/or periventricular leukomalacia was observed.
近期使用的产前类固醇用于诱导胎儿肺成熟仍是治疗早产的标准程序。然而,产前类固醇对胎儿的影响可能并非只有积极的一面。
研究产前类固醇对体重低于1000克的极低出生体重新生儿的总死亡率和严重发病率的作用。
比较病例对照研究。
捷克共和国布拉格母婴护理研究所。
55例使用了产前类固醇(ANS+组),65例对照新生儿未使用类固醇(ANS-组)。两个研究组在出生体重、胎龄、性别、分娩方式和宫内生长迟缓情况方面具有可比性。胎膜早破时间存在统计学显著差异(ANS+组为108±228小时,ANS-组为27±56小时,p<0.007)。使用Epi Info 6(美国疾病控制与预防中心)软件包和方差分析进行统计分析。
我们发现总死亡率(ANS+组为22%,ANS-组为45%,p<0.008)、呼吸窘迫综合征严重程度(ANS+组中位数为2,ANS-组中位数为3,p<0.0008)、表面活性剂总累积剂量(ANS+组为73毫克,ANS-组为111毫克,p<0.0003)、脑室周围-脑室内出血发生率(ANS+组中位数为1,ANS-组中位数为2,p<0.005)和出血后脑积水(ANS+组为6%,ANS-组为23%,p<0.008)存在统计学显著差异。CRIB值(ANS+组中位数为7,ANS-组中位数为11,p<0.007)和NEOMOD值(ANS+组中位数为5,ANS-组中位数为7,p<0.002)也存在统计学显著差异。在其他参数(气胸、败血症、动脉导管未闭、坏死性小肠结肠炎、脑室周围白质软化)方面未发现统计学差异。
我们的研究证实了产前类固醇对死亡率、严重呼吸疾病发病率和脑室内出血发生率有积极作用。未观察到产前类固醇对感染并发症和/或脑室周围白质软化发生率较高有负面影响。